165 related articles for article (PubMed ID: 20946148)
21. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.
Dennis J; Medina-Rivera A; Truong V; Antounians L; Zwingerman N; Carrasco G; Strug L; Wells P; Trégouët DA; Morange PE; Wilson MD; Gagnon F
Genet Epidemiol; 2017 Jul; 41(5):455-466. PubMed ID: 28421636
[TBL] [Abstract][Full Text] [Related]
22. Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Factor V Leiden Mutation.
Al-Awadhi A; Marouf R; Jadaon MM; Al-Awadhy MM
Clin Appl Thromb Hemost; 2024; 30():10760296231223195. PubMed ID: 38225166
[TBL] [Abstract][Full Text] [Related]
23. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.
Bruzelius M; Iglesias MJ; Hong MG; Sanchez-Rivera L; Gyorgy B; Souto JC; Frånberg M; Fredolini C; Strawbridge RJ; Holmström M; Hamsten A; Uhlén M; Silveira A; Soria JM; Smadja DM; Butler LM; Schwenk JM; Morange PE; Trégouët DA; Odeberg J
Blood; 2016 Dec; 128(23):e59-e66. PubMed ID: 27742707
[TBL] [Abstract][Full Text] [Related]
24. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
[TBL] [Abstract][Full Text] [Related]
25. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
[TBL] [Abstract][Full Text] [Related]
26. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism risk associated with ABO, F11 and FGG loci.
Manco L; Silva C; Fidalgo T; Martinho P; Sarmento AB; Ribeiro ML
Blood Coagul Fibrinolysis; 2018 Sep; 29(6):528-532. PubMed ID: 29995659
[TBL] [Abstract][Full Text] [Related]
28. Elevated Von Willebrand Factor Antigen Levels are an Independent Risk Factor for Venous Thromboembolism: First Report from North India.
Rajpal S; Ahluwalia J; Kumar N; Malhotra P; Uppal V
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):489-495. PubMed ID: 31388262
[TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
[TBL] [Abstract][Full Text] [Related]
30. Genetic regulation of plasma von Willebrand factor levels in health and disease.
Swystun LL; Lillicrap D
J Thromb Haemost; 2018 Dec; 16(12):2375-2390. PubMed ID: 30246494
[TBL] [Abstract][Full Text] [Related]
31. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
[TBL] [Abstract][Full Text] [Related]
32. von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications.
Calabrò P; Gragnano F; Golia E; Grove EL
Semin Thromb Hemost; 2018 Apr; 44(3):249-260. PubMed ID: 28898897
[TBL] [Abstract][Full Text] [Related]
33. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.
Lindström S; Wang L; Smith EN; Gordon W; van Hylckama Vlieg A; de Andrade M; Brody JA; Pattee JW; Haessler J; Brumpton BM; Chasman DI; Suchon P; Chen MH; Turman C; Germain M; Wiggins KL; MacDonald J; Braekkan SK; Armasu SM; Pankratz N; Jackson RD; Nielsen JB; Giulianini F; Puurunen MK; Ibrahim M; Heckbert SR; Damrauer SM; Natarajan P; Klarin D; ; de Vries PS; Sabater-Lleal M; Huffman JE; ; Bammler TK; Frazer KA; McCauley BM; Taylor K; Pankow JS; Reiner AP; Gabrielsen ME; Deleuze JF; O'Donnell CJ; Kim J; McKnight B; Kraft P; Hansen JB; Rosendaal FR; Heit JA; Psaty BM; Tang W; Kooperberg C; Hveem K; Ridker PM; Morange PE; Johnson AD; Kabrhel C; Trégouët DA; Smith NL
Blood; 2019 Nov; 134(19):1645-1657. PubMed ID: 31420334
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
van Loon J; Dehghan A; Weihong T; Trompet S; McArdle WL; Asselbergs FW; Chen MH; Lopez LM; Huffman JE; Leebeek FW; Basu S; Stott DJ; Rumley A; Gansevoort RT; Davies G; Wilson JJ; Witteman JC; Cao X; de Craen AJ; Bakker SJ; Psaty BM; Starr JM; Hofman A; Wouter Jukema J; Deary IJ; Hayward C; van der Harst P; Lowe GD; Folsom AR; Strachan DP; Smith N; de Maat MP; O'Donnell C
Eur J Hum Genet; 2016 Jul; 24(7):1035-40. PubMed ID: 26486471
[TBL] [Abstract][Full Text] [Related]
36. Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.
Cunha MLR; Meijers JCM; Rosendaal FR; Vlieg AVH; Reitsma PH; Middeldorp S
PLoS One; 2017; 12(11):e0187699. PubMed ID: 29117201
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
[TBL] [Abstract][Full Text] [Related]
38. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.
Campos M; Buchanan A; Yu F; Barbalic M; Xiao Y; Chambless LE; Wu KK; Folsom AR; Boerwinkle E; Dong JF
Blood; 2012 Feb; 119(8):1929-34. PubMed ID: 22219226
[TBL] [Abstract][Full Text] [Related]
39. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.
Smith NL; Chen MH; Dehghan A; Strachan DP; Basu S; Soranzo N; Hayward C; Rudan I; Sabater-Lleal M; Bis JC; de Maat MP; Rumley A; Kong X; Yang Q; Williams FM; Vitart V; Campbell H; Mälarstig A; Wiggins KL; Van Duijn CM; McArdle WL; Pankow JS; Johnson AD; Silveira A; McKnight B; Uitterlinden AG; ; Aleksic N; Meigs JB; Peters A; Koenig W; Cushman M; Kathiresan S; Rotter JI; Bovill EG; Hofman A; Boerwinkle E; Tofler GH; Peden JF; Psaty BM; Leebeek F; Folsom AR; Larson MG; Spector TD; Wright AF; Wilson JF; Hamsten A; Lumley T; Witteman JC; Tang W; O'Donnell CJ
Circulation; 2010 Mar; 121(12):1382-92. PubMed ID: 20231535
[TBL] [Abstract][Full Text] [Related]
40. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
